EverSource Wealth Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
WPC
PCM
MWM
CL
MNBTD
LSERS
EverSource Wealth Advisors's NEO Position: Q2 2026 in Review
EverSource Wealth Advisors increased its NeoGenomics (NEO) stake by 80% in Q2 2026, buying an estimated $4.57K and bringing the position to 1,066 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2622.
EverSource Wealth Advisors first reported a position in NEO in Q4 2021 and has held it in 19 quarters since. The position peaked at $16.3K in Q3 2024. 69 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- EverSource Wealth Advisors held 1,066 shares of NeoGenomics worth $15.6K as of Q2 2026.
- EverSource Wealth Advisors bought 474 NeoGenomics shares in Q2 2026, an estimated $4.57K.
- NeoGenomics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2622 holding.
- EverSource Wealth Advisors first reported a position in NeoGenomics in Q4 2021 and has held it in 19 quarters since.
- EverSource Wealth Advisors's NeoGenomics position peaked at $16.3K in Q3 2024.
- 69 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.